• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Technology·ICCT
Share

iCoreConnect Inc. Stocks

$ 0Last Updated 26.06.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

$ 5365

$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

iCoreConnect Inc. develops and markets health insurance portability and accountability act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company offers iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, an add-on for iCoreRx that integrates with state databases to automate prescription drug monitoring; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patient insurance eligibility breakdown to verify their benefits; iCoreClaims for processing and managing claims submitted by policyholders or dental care provider; and iCoreHuddle and iCoreHuddle+, which reveals the revenue potential of each patient. It also provides iCoreCodeGenius, a medical coding reference SaaS solution; iCoreExchange, a HIPAA compliant SaaS email solution using direct protocol that allows doctors to send and receive secure email with attachments to and from other healthcare professionals in the network; iCoreCloud provides the ability to backup on-premise servers and computers to the cloud; iCorePay, a cloud-based financial technology solution designed to streamline the billing and payment processes for healthcare providers; iCoreSecure, a secure SaaS solution that solves privacy concerns; and iCoreIT. In addition, the company offers iCoreVerify provides automated insurance verifications; iCoreVerify+ that combines automation with concierge assistance for verification; and iCoreVerifyPro, it manages all verifications, entering insurance benefits directly into patient charts, ensuring insurance information. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. The company was founded in 1992 and is headquartered in Ocoee, Florida. On June 2, 2025, iCoreConnect Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

29.10.2026 01:34

Microsoft Beat Forecasts for Cloud Revenue

29.10.2026 01:17

Alphabet shares fell 7%: revenue and earnings came in below expectations

29.10.2026 01:07

The U.S. Federal Reserve will reduce the number of interest rate meetings starting in 2027

29.10.2026 00:35

Is this the end of the “Magnificent Seven”? Big Tech stocks have diverged in their performance. Which ones should you choose?

29.10.2026 00:10

Oracle surprised the market with its cash flow forecast. Its shares soared 12%.

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026